Displaying drugs 101 - 125 of 2797 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Simeprevir | 749.939 C38H47N5O7S2 | A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. | Antivirals for treatment of HCV infections / Protease Inhibitors / Sulfonamides | |
Iodixanol | 1550.1819 C35H44I6N6O15 | A contrast agent used during coronary angiography, particularly in patients with renal dysfunction. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media | |
Opicapone | 413.17 C15H10Cl2N4O6 | A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. | COMT Inhibitors | |
Light mineral oil | Not Annotated | An oil used to hydrate dry, itchy skin, hemorrhoids, and dry eyes. | Basic Ointments and Protectants | |
Resmetirom | 435.22 C17H12Cl2N6O4 | A thyroid hormone receptor-beta agonist used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis in adults. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OATP1B3 substrates / Pyrimidines / Pyrimidinones / Thyroid hormone receptor-beta (THR-beta) agonist / UGT1A4 Inhibitors / UGT1A9 Inhibitors | |
Tetrachlorodecaoxide | 319.821 Cl4H2O11 | Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, cancer/tumors (unspecified), HIV infection, and inflammatory disorders (unspecified). | Radiation-Protective Agents | |
Setmelanotide | 1117.32 C49H68N18O9S2 | A drug indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. | Centrally Acting Antiobesity Products | |
P-nitrobiphenyl | 199.209 C12H9NO2 | Pnb has been used in trials studying the treatment of Pelvic Organ Prolapse. | Not Annotated | |
Proflavine | 209.2465 C13H11N3 | A topical antiseptic agent used in wound dressings to prevent infections. | Aminoacridines / Anti-Infective Agents, Local | |
Pilocarpine | 208.2569 C11H16N2O2 | A muscarinic agonist used to treat dry mouth and various ophthalmic conditions, such as presbyopia, increased intraocular pressure, and angle-closure glaucoma. | Parasympathomimetics | |
Phenyltoloxamine | 255.361 C17H21NO | A medication used to treat minor aches and pains. | Benzene Derivatives | |
Lithium citrate | 209.92 C6H5Li3O7 | Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment. | Lithium Compounds / Mood Stabilizer | |
Vemurafenib | 489.922 C23H18ClF2N3O3S | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors / Sulfonamides | |
Cefdinir | 395.414 C14H13N5O5S2 | A third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections. | Anti-Bacterial Agents / Third-Generation Cephalosporins | |
Letermovir | 572.561 C29H28F4N4O4 | An antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease. | Antiviral Agents / Cytomegalovirus DNA Terminase Complex Inhibitor / Poly(ADP-ribose) Polymerase Inhibitors | |
Bromfenac | 334.165 C15H12BrNO3 | An NSAID used to treat postoperative pain and inflammation of the eye. | Anti-Inflammatory Agents, Non-Steroidal | |
Naldemedine | 570.646 C32H34N4O6 | An opioid antagonist used to to treat opioid-induced constipation. | Peripheral Opioid Receptor Antagonists | |
Methylnaltrexone | 356.441 C21H26NO4 | A μ-opioid antagonist used for the treatment of opioid-induced constipation in palliative patients that are inadequately responding to laxative therapy. | Peripheral Opioid Receptor Antagonists | |
Methylprednisone | 372.461 C22H28O5 | Methylprednisone has been used in trials studying the treatment of Leukemia, Rheumatoid Arthritis, Renal Transplantation, Kidney Transplantation, and Acute Lymphocytic Leukemia, among others. | Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 Substrates | |
Enzalutamide | 464.436 C21H16F4N4O2S | A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. | Antiandrogens | |
Diphenoxylate | 452.5873 C30H32N2O2 | An antidiarrheal medication used with atropine to manage diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome | |
Bemiparin | Not Available | An ultra-low molecular weight heparin (ultra-LMWH) used to prevent thromboembolism following surgery and extracorporeal clotting during dialysis. | Anticoagulants | |
Metacycline | 442.424 C22H22N2O8 | For the treatment of acute bacterial exacerbations of chronic bronchitis | Tetracyclines | |
Ropinirole | 260.3746 C16H24N2O | A non-ergoline dopamine agonist used to treat the symptoms of Parkinson's disease and Restless Legs Syndrome. | Anti-Parkinson Drugs / Dopamine Agents | |
Brexpiprazole | 433.57 C25H27N3O2S | A serotonin–dopamine activity modulator used in the treatment of major depressive disorder as an adjunct, schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. | Agents that produce hypertension / Neurotoxic agents |
Displaying drugs 101 - 125 of 2797 in total